These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7454878)

  • 21. [Clinical pharmacology of legalon (review of the literature)].
    Skakun NP; Moseĭchuk IP
    Vrach Delo; 1988 May; (5):5-10. PubMed ID: 3047986
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro inhibition of adenosine deaminase by flavonoids and related compounds. New insight into the mechanism of action of plant phenolics.
    Koch HP; Jäger W; Groh U; Plank G
    Methods Find Exp Clin Pharmacol; 1992; 14(6):413-7. PubMed ID: 1469950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of human polymorphonuclear leukocyte function by the flavonoid silybin.
    Minonzio F; Venegoni E; Ongari AM; Ciani D; Capsoni F
    Int J Tissue React; 1988; 10(4):223-31. PubMed ID: 2855072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes, induced by certain flavonoids, of the hypotensive effects of arachidonic acid].
    Damas J; Mousty JC; Lecomte J
    C R Seances Soc Biol Fil; 1977; 171(1):257-60. PubMed ID: 143326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of silymarin (Carsil) on the microsomal glycoprotein and protein biosynthesis in liver of rats with experimental galactosamine hepatitis.
    Tyutyulkova N; Gorantcheva U; Tuneva S; Chelibonova-Lorer H; Gavasova E; Zhivkov V
    Methods Find Exp Clin Pharmacol; 1983; 5(3):181-4. PubMed ID: 6888084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of silybin action, IV. Structure-action relationship (author's transl)].
    Sonnenbichler J; Pohl A
    Hoppe Seylers Z Physiol Chem; 1980 Nov; 361(11):1757-61. PubMed ID: 6161072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
    Koch HP; Bachner J; Löffler E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 29. Antihepatotoxic flavonoids.
    Wagner H
    Prog Clin Biol Res; 1986; 213():545-58. PubMed ID: 3520594
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of silybin on liver phospholipid synthesis in the rat in vivo.
    Montanini I; Castigli E; Arienti UG; Porcellati G
    Farmaco Sci; 1977 Feb; 32(2):141-6. PubMed ID: 870340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Depression of microsomal activity in the liver of mice following single administration of halothane and its influencibility by silybin].
    Janiak B
    Anaesthesist; 1974 Sep; 23(9):389-93. PubMed ID: 4458505
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aspects of liver damage after experimental administration of some drugs. Preliminary note].
    Martines G; Copponi V; Cagnetta G
    Arch Sci Med (Torino); 1980; 137(3):367-86. PubMed ID: 7235927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological responses to a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: II. alterations in thymic differentiation correlate with changes in c-myc gene expression.
    Johnson VJ; Osuchowski MF; He Q; Sharma RP
    Planta Med; 2002 Nov; 68(11):961-5. PubMed ID: 12451483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phalloidine antagonists. 1. Effects of silybine derivatives on isolated perfused rat liver].
    Frimmer VM; Kroker R
    Arzneimittelforschung; 1975 Mar; 25(3):394-6. PubMed ID: 1174040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silybin inhibition of human T-lymphocyte activation.
    Meroni PL; Barcellini W; Borghi MO; Vismara A; Ferraro G; Ciani D; Zanussi C
    Int J Tissue React; 1988; 10(3):177-81. PubMed ID: 3265704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibition of the enzyme-catalyzed degradation of indole-3-acetic acid by silybin, dilydianin, and Silychristin (author's transl)].
    Greimel A; Koch H
    Planta Med; 1977 Dec; 32(4):331-41. PubMed ID: 594207
    [No Abstract]   [Full Text] [Related]  

  • 38. Silybin inhibition of amatoxin uptake in the perfused rat liver.
    Faulstich H; Jahn W; Wieland T
    Arzneimittelforschung; 1980; 30(3):452-4. PubMed ID: 7387753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of silybin on hemodynamics in anesthetized open-chest cats].
    Rui YC; Chen XS; Guan AH; Han JS
    Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):34-6. PubMed ID: 2945381
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacologic properties of silybin and silymarin].
    Lecomte J
    Rev Med Liege; 1975 Feb; 30(4):110-4. PubMed ID: 1224091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.